Case ReportTrazodone (cas 19794-93-5) induced galactorrhea: a case report☆

Add time:10/01/2019    Source:sciencedirect.com

Trazodone is a heterocyclic antidepressant that exerts its effect via the inhibition of selective serotonin reuptake and the antagonism of 5-HT2A and 5-HT2C receptors. Antidepressant-induced galactorrhea and increases in prolactin levels have rarely been reported. Trazodone can potentiate the serotonergic activity of citalopram. To our knowledge, no cases of galactorrhea associated with use of trazodone have been reported to date. This report describes a unique case of the development of galactorrhea following the addition of trazodone (100 mg/day, 2 weeks) to the treatment of a patient who was receiving citalopram (40 mg/day, 6 weeks) therapy for a diagnosis of depressive disorder, which improved upon the discontinuation of trazodone.

We also recommend Trading Suppliers and Manufacturers of Trazodone (cas 19794-93-5). Pls Click Website Link as below: cas 19794-93-5 suppliers

Prev:Postmortem distribution of Trazodone (cas 19794-93-5) concentrations
Next:Mutagenicity and recombinogenicity evaluation of bupropion hydrochloride and Trazodone (cas 19794-93-5) hydrochloride in somatic cells of Drosophila melanogaster)